ALFA Finder India's fastest NSE & BSE filing alerts on Telegram, filtered to the stocks you hold Telegram alerts alfafinder.com →
Thursday, 12 November 2026 Every NSE & BSE announcement, by company
ALFA Filings Every announcement, straight from the exchange
Earnings Call

KRM Ayurveda Earnings Call: Key Takeaways

KRM Ayurveda crossed ₹100 Cr revenue in FY26, reporting 32.84% growth. Strategy focuses on integrated healthcare through hospital expansion, specialty Ayurvedic care, and digital telehealth.

Highlights
Revenue growthFY26 revenue up 32.84% YoY to ₹101.69 Cr.
MarginsEBITDA margin improved from 25.0% in FY25 to 30.6% in FY26.
Demand visibilityStrong; 69% bed occupancy and 8 lakh+ YouTube followers drive reach.
Management confidenceHigh; MD cites 'transformational year' and strengthened post-IPO balance sheet.

Growth

FY26 Revenue ₹101.69 Cr (+32.8% YoY); PAT ₹20.12 Cr (+79.4% YoY). EBITDA margins expanded to 30.6%.

Outlook

Targets 500-seated telemedicine team and global outreach. Expanding product portfolio and medical tourism packages.

Risks

Dependence on Ayurvedic adoption; high competition in the wellness sector; regional concentration in North India.

Source

Earnings Call filed with NSE, NSE: KRMAYURVED. Summary written with AI assistance from the document.

Read the document ↗

KRM Ayurveda Ltd: key numbers

Share price
₹245.00
Market cap
₹520.9 Cr
Revenue (annual)
₹101.7 Cr
Net profit (annual)
₹20.12 Cr
P/E (TTM)
25.9×Sector 35.3×
Promoter holding
69.30%+0.00% QoQ
FII holding
1.54%Current quarter

Reference market data from a third-party provider, updated daily. Not a valuation or a recommendation.

More from KRM Ayurveda Ltd

All →